GENE ONLINE|News &
A New Paradigm in Biotech Innovation and Investment
Asia-based biotech investment and venture capital were among the topics discussed at the Bio Asia-Taiwan international conference. We bring to you some key takeaways from the discussions.
Todd Kaloudis, Managing Director, Cobro Ventures, presented his views about why US venture capitalists (VCs) team up with Asia-based investors. Having worked with many in the past, he observes advantages in these collaborations.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
